TaiMed Biologics Inc. (TPEX:4147)

Taiwan · Delayed Price · Currency is TWD

52.90

+4.75 (9.87%)

Mar 24, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research and Development and Sales of New Drugs	611.35M	610.16M	491.78M	563.01M	413.44M
Research and Development and Sales of New Drugs Growth	0.19%	24.07%	-12.65%	36.18%	-42.78%
Total	611.35M	610.16M	491.78M	563.01M	413.44M
Total Growth	0.19%	24.07%	-12.65%	36.18%	-42.78%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	611.35M	610.16M	491.78M	563.01M	413.44M
Taiwan Growth	0.19%	24.07%	-12.65%	36.18%	-42.78%
Total	611.35M	610.16M	491.78M	563.01M	413.44M
Total Growth	0.19%	24.07%	-12.65%	36.18%	-42.78%

Source: S&P Global Market Intelligence.